Outcome of Pregnancy in Renal Transplant Recipients Taking Cyclosporin A

Pregnancy-induced changes increase hazards associated with cyclosporine (CsA) treatment. Blood CsA trough levels (C0) were estimated in 15 pregnant renal allograft recipients treated with prednisolone + CsA + azathioprine using the TDx Abbott fluorescent polarization immunoassay. Despite therapeutical dose levels of CsA administered during pregnancy (3.52-3.67 and 3.59 mg/kg body weight in the first, second, and third trimesters, respectively), C0 significantly decreased (first trimester 130.8 +/- 36.9, second 92.0 +/- 32.7, and third 99.0 +/- 36.9 ng/ml). The mean increase of patient's body weight in mid-pregnancy was 3.0 +/- 2.19 kg and was associated with a significant (P < 0.05) fall in a hematocrit value (from 42 +/- 4.9% prior to pregnancy to 34 +/- 6% at the 20th week). We postulate that C0 concentration does not reflect the true exposure to CsA as no episodes of acute graft rejection were observed during pregnancy.

show abstract

Cyclosporine A blood concentration during pregnancy in renal allograft recipients

Kozłowska-Boszko¹,

Gaciong²,

Serafinowicz³

et al. 1998

Transplant International

View full text Add to dashboard Cite

show abstract

Pregnancy Outcome After Cyclosporine Therapy During Pregnancy: A Meta-Analysis1

Hackman²,

Einarson³

et al. 2001

Transplantation

390

157

View full text Add to dashboard Cite

show abstract

Cyclosporine A blood concentration during pregnancy in renal allograft recipients

Kozłowska-Boszko¹,

Gaciong²,

Serafinowicz³

et al. 1998

Transplant Int

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Outcome of Pregnancy in Renal Transplant Recipients Taking Cyclosporin A

Cited by 5 publications

References 6 publications

Cyclosporine A blood concentration during pregnancy in renal allograft recipients

Cyclosporine A blood concentration during pregnancy in renal allograft recipients

Pregnancy Outcome After Cyclosporine Therapy During Pregnancy: A Meta-Analysis1

Cyclosporine A blood concentration during pregnancy in renal allograft recipients

Contact Info

Product

Resources

About